Literature DB >> 9515816

Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.

D Mukhopadhyay1, J A Nagy, E J Manseau, H F Dvorak.   

Abstract

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is a multifunctional cytokine and growth factor that has important roles in both pathological and physiological angiogenesis. VPF/VEGF induces vascular hyperpermeability, cell division, and other activities by interacting with two specific receptor tyrosine kinases, KDR/Flk-1 and Flt-1, that are selectively expressed on vascular endothelium. The signaling cascade that follows VPF/VEGF interaction with cultured endothelium is only partially understood but is known to result in increased intracellular calcium, activation of protein kinase C, and tyrosine phosphorylations of both receptors, phospholipase C-gamma (PLC-gamma) and phosphatidylinositol 3'-kinase. For many reasons, signaling events elicited in cultured endothelium may not mimic mediator effects on intact normal or tumor-induced microvessels in vivo. Therefore, we developed a system that would allow measurement of VPF/VEGF-induced signaling on intact microvessels. We used mouse mesentery, a tissue whose numerous microvessels are highly responsive to VPF/VEGF and that we found to express Flk-1 and Flt-1 selectively. At intervals after injecting VPF/VEGF i.p., mesenteries were harvested, extracted, and immunoprecipitated. Immunoblots confirmed that VPF/VEGF induced tyrosine phosphorylation of several proteins in mesenteric microvessels as in cultured endothelium: Flk-1; PLC-gamma; and mitogen-activated protein kinase. Similar phosphorylations were observed when mesentery was exposed to VPF/VEGF in vitro, or when mesenteries were harvested from mice bearing the mouse ovarian tumor ascites tumor, which itself secretes abundant VPF/VEGF. Other experiments further elucidated the VPF/VEGF signaling pathway, demonstrating phosphorylation of both PYK2 and focal adhesion kinase, activation of c-jun-NH2-kinase with phosphorylation of c-Jun, and an association between Flk-1 and PLC-gamma. In addition, we demonstrated translocation of mitogen-activated protein kinase to the cell nucleus in cultured endothelium. Taken together, these experiments describe a new model system with the potential for investigating signaling events in response to diverse mediators on intact microvessels in vivo and have further elucidated the VPF/VEGF signaling cascade.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515816

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways.

Authors:  D O Bates; R I Heald; F E Curry; B Williams
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

2.  Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo.

Authors:  Shang Shen; Jie Fan; Bin Cai; Yonggang Lv; Min Zeng; Yanyan Hao; Filippo G Giancotti; Bingmei M Fu
Journal:  Exp Physiol       Date:  2009-10-30       Impact factor: 2.969

Review 3.  Microvascular transport and tumor cell adhesion in the microcirculation.

Authors:  Bingmei M Fu; Yang Liu
Journal:  Ann Biomed Eng       Date:  2012-04-03       Impact factor: 3.934

Review 4.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  In vivo mechanisms of vascular endothelial growth factor-mediated increased hydraulic conductivity of Rana capillaries.

Authors:  T M Pocock; D O Bates
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

6.  A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.

Authors:  H Gille; J Kowalski; L Yu; H Chen; M T Pisabarro; T Davis-Smyth; N Ferrara
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

Review 7.  Regulation of microvascular permeability by vascular endothelial growth factors.

Authors:  D O Bates; N J Hillman; B Williams; C R Neal; T M Pocock
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

8.  Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugs.

Authors:  Eugene A Woltering; James M Lewis; P Johnstone Maxwell; Daniel J Frey; Yi-Zarn Wang; John Rothermel; Catherine T Anthony; Douglas A Balster; J Patrick O'Leary; Lynn H Harrison
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

9.  Adhesion of malignant mammary tumor cells MDA-MB-231 to microvessel wall increases microvascular permeability via degradation of endothelial surface glycocalyx.

Authors:  Bin Cai; Jie Fan; Min Zeng; Lin Zhang; Bingmei M Fu
Journal:  J Appl Physiol (1985)       Date:  2012-08-02

10.  Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.

Authors:  Xinyuan Zhang; Shisan Bao; Donna Lai; Robert W Rapkins; Mark C Gillies
Journal:  Diabetes       Date:  2008-01-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.